223 related articles for article (PubMed ID: 28705642)
1. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
[No Abstract] [Full Text] [Related]
2. Corrigendum to "Acetazolamide-based [
More KN; Lee JY; Kim DY; Cho NC; Pyo A; Yun M; Kim HS; Kim H; Ko K; Park JH; Chang DJ
Bioorg Med Chem Lett; 2018 Aug; 28(14):2574. PubMed ID: 29929883
[No Abstract] [Full Text] [Related]
3. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
Kang ST; Kim EY; Achary R; Jung H; Park CH; Yun CS; Hwang JY; Choi SU; Chae C; Lee CO; Kim HR; Ha JD; Ryu D; Cho SY
Bioorg Med Chem Lett; 2017 Jul; 27(14):3205. PubMed ID: 28551102
[No Abstract] [Full Text] [Related]
5. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484].
Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
[No Abstract] [Full Text] [Related]
7. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].
Jadhav GR; Sinha S; Chhabra M; Paira P
Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
Sekhar KVGC; Rao VS; Devambatla RKV; Kumar MMK
Bioorg Med Chem Lett; 2017 May; 27(9):2081. PubMed ID: 28336140
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
Kim SH; Johnson JA; Jiang J; Parkhurst B; Phillips M; Pi Z; Qiao JX; Tora G; Ye Chen A; Liu E; Yin X; Yang R; Zhao L; Taylor DS; Basso M; Behnia K; Onorato J; Chen XQ; Abell LM; Lu H; Locke G; Caporuscio C; Adam LP; Gordon D; Wexler RR; Finlay HJ
Bioorg Med Chem Lett; 2019 Sep; 29(17):2525. PubMed ID: 31353296
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
[No Abstract] [Full Text] [Related]
12. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390].
Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X
Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts" [Bioorg. Med. Chem. Lett. 27 (22) (2017) 4975-4978].
Kato H; Kai A; Kawabata T; Sunderhaus JD; McAfoos TJ; Finefield JM; Sugimoto Y; Williams RM; Tsukamoto S
Bioorg Med Chem Lett; 2018 Aug; 28(14):2573. PubMed ID: 29903661
[No Abstract] [Full Text] [Related]
14. Retraction notice to "Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones" [Bioorg. Med. Chem. Lett. 26 (2016) 3093-3097].
Lamie PF
Bioorg Med Chem Lett; 2017 Sep; 27(17):4220. PubMed ID: 28826507
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors" [Bioorg. Med. Chem. Lett. 31 (2021) 127710].
Xiang HY; Chen JY; Huan XJ; Chen Y; Gao ZB; Ding J; Miao ZH; Yang CH
Bioorg Med Chem Lett; 2022 Jan; 56():128501. PubMed ID: 34911648
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369].
Zheng H; Wei Z; Xin G; Ji C; Wen L; Xia Q; Niu H; Huang W
Bioorg Med Chem Lett; 2016 Sep; 26(17):4386. PubMed ID: 27474444
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].
Abdelall EKA; Abdelhamid AO; Azouz AA
Bioorg Med Chem Lett; 2018 Feb; 28(4):839. PubMed ID: 29395977
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066].
Sheffler DJ; Nedelcovych MT; Williams R; Turner SC; Duerk BB; Robbins MR; Jadhav SB; Niswender CM; Jones CK; Conn PJ; Nathan Daniels R; Lindsley CW
Bioorg Med Chem Lett; 2017 May; 27(9):2079. PubMed ID: 28347668
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Solid-phase synthesis of Biotin-S-Farnesyl-l-Cysteine, a surrogate substrate for isoprenylcysteine Carboxylmethyltransferase (ICMT)" [Bioorg. Med. Chem. Lett. 23 (2013) [5671-5673].
Stevenson GI; Yong S; Fechner GA; Neve J; Lock A; Avery VM
Bioorg Med Chem Lett; 2018 Aug; 28(14):2575. PubMed ID: 30007572
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA
Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD
Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
